<s id="wsj_2336.1"> 30
2 	 0 	 N/N 	 1 	 Inc. MedChem
2 	 1 	 N/N 	 1 	 Inc. Products
2 	 3 	 (S[dcl]\NP)/S[dcl] 	 1 	 Inc. said
7 	 4 	 NP[nb]/N 	 1 	 Court a
7 	 5 	 N/N 	 1 	 Court U.S.
7 	 6 	 N/N 	 1 	 Court District
7 	 8 	 (NP\NP)/NP 	 1 	 Court in
7 	 10 	 (S[dcl]\NP)/S[em] 	 1 	 Court ruled
9 	 8 	 (NP\NP)/NP 	 2 	 Boston in
10 	 3 	 (S[dcl]\NP)/S[dcl] 	 2 	 ruled said
11 	 10 	 (S[dcl]\NP)/S[em] 	 2 	 that ruled
13 	 12 	 NP[nb]/N 	 1 	 challenge a
13 	 14 	 (NP\NP)/NP 	 1 	 challenge by
13 	 16 	 (NP\NP)/NP 	 1 	 challenge to
13 	 27 	 (S[dcl]\NP)/PP 	 1 	 challenge was
15 	 14 	 (NP\NP)/NP 	 2 	 MedChem by
18 	 16 	 (NP\NP)/NP 	 2 	 validity to
18 	 17 	 NP[nb]/N 	 1 	 validity the
18 	 19 	 (NP\NP)/NP 	 1 	 validity of
22 	 19 	 (NP\NP)/NP 	 2 	 patent of
22 	 20 	 NP[nb]/N 	 1 	 patent a
22 	 21 	 N/N 	 1 	 patent U.S.
22 	 23 	 S[pss]\NP 	 1 	 patent held <XB>
23 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 held by
26 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 Inc. by
26 	 25 	 N/N 	 1 	 Inc. Pharmacia
27 	 11 	 S[em]/S[dcl] 	 1 	 was that
28 	 27 	 (S[dcl]\NP)/PP 	 2 	 without was
29 	 28 	 PP/NP 	 1 	 merit without
<\s>
<s id="wsj_2336.2"> 26
0 	 2 	 S[pss]\NP 	 1 	 Pharmacia based <XB>
0 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Pharmacia had
0 	 9 	 (S[pt]\NP)/S[em] 	 1 	 Pharmacia charged <XB>
2 	 3 	 ((S\NP)\(S\NP))/NP 	 2 	 based in
4 	 3 	 ((S\NP)\(S\NP))/NP 	 3 	 Upsala in
6 	 3 	 ((S\NP)\(S\NP))/NP 	 3 	 Sweden in
9 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 charged had
9 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 charged in
12 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 lawsuit in
12 	 11 	 NP[nb]/N 	 1 	 lawsuit a
12 	 13 	 (NP\NP)/NP 	 1 	 lawsuit against
14 	 13 	 (NP\NP)/NP 	 2 	 MedChem against
15 	 9 	 (S[pt]\NP)/S[em] 	 2 	 that charged
16 	 17 	 (NP[nb]/N)\NP 	 2 	 MedChem 's
20 	 17 	 (NP[nb]/N)\NP 	 1 	 line 's
20 	 18 	 N/N 	 1 	 line AMVISC
20 	 19 	 N/N 	 1 	 line product
20 	 21 	 (S[dcl]\NP)/PP 	 1 	 line infringes
21 	 15 	 S[em]/S[dcl] 	 1 	 infringes that
22 	 21 	 (S[dcl]\NP)/PP 	 2 	 on infringes
25 	 22 	 PP/NP 	 1 	 patent on
25 	 23 	 NP[nb]/N 	 1 	 patent the
25 	 24 	 N/N 	 1 	 patent Pharmacia
<\s>
<s id="wsj_2336.3"> 15
1 	 0 	 NP[nb]/N 	 1 	 patent The
1 	 2 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 patent is
1 	 3 	 (S[adj]\NP)/PP 	 1 	 patent related <XB>
3 	 2 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 related is
4 	 3 	 (S[adj]\NP)/PP 	 2 	 to related
6 	 4 	 PP/NP 	 1 	 acid to
6 	 5 	 N/N 	 1 	 acid hyaluronic
10 	 4 	 PP/NP 	 1 	 extract to
10 	 8 	 NP[nb]/N 	 1 	 extract a
10 	 9 	 N/N 	 1 	 extract rooster-comb
10 	 11 	 S[pss]\NP 	 1 	 extract used <XB>
11 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 used in
14 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 surgery in
14 	 13 	 N/N 	 1 	 surgery eye
<\s>
<s id="wsj_2336.4"> 21
2 	 0 	 (S/S)/NP 	 2 	 lawsuit In
2 	 1 	 NP[nb]/N 	 1 	 lawsuit its
4 	 5 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 Pharmacia is
4 	 6 	 (S[ng]\NP)/NP 	 1 	 Pharmacia seeking <XB>
5 	 0 	 (S/S)/NP 	 1 	 is In
6 	 5 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 seeking is
8 	 6 	 (S[ng]\NP)/NP 	 2 	 damages seeking
8 	 7 	 N/N 	 1 	 damages unspecified
12 	 6 	 (S[ng]\NP)/NP 	 2 	 injunction seeking
12 	 10 	 NP[nb]/N 	 1 	 injunction a
12 	 11 	 N/N 	 1 	 injunction preliminary
14 	 13 	 (S[to]\NP)/(S[b]\NP) 	 2 	 block to
15 	 14 	 ((S[b]\NP)/PP)/NP 	 3 	 MedChem block
16 	 14 	 ((S[b]\NP)/PP)/NP 	 2 	 from block
17 	 16 	 PP/(S[ng]\NP) 	 1 	 selling from
20 	 17 	 (S[ng]\NP)/NP 	 2 	 products selling
20 	 18 	 NP[nb]/N 	 1 	 products the
20 	 19 	 N/N 	 1 	 products AMVISC
<\s>
<s id="wsj_2336.5"> 23
2 	 0 	 NP[nb]/N 	 1 	 spokesman A
2 	 1 	 N/N 	 1 	 spokesman MedChem
2 	 3 	 (S[dcl]\NP)/S[dcl] 	 1 	 spokesman said
5 	 4 	 NP[nb]/N 	 1 	 products the
5 	 6 	 (S[dcl]\NP)/NP 	 1 	 products contribute
6 	 3 	 (S[dcl]\NP)/S[dcl] 	 2 	 contribute said
9 	 6 	 (S[dcl]\NP)/NP 	 2 	 third contribute
9 	 7 	 NP/NP 	 1 	 third about
9 	 8 	 NP[nb]/N 	 1 	 third a
9 	 10 	 (NP\NP)/NP 	 1 	 third of
11 	 12 	 (NP[nb]/N)\NP 	 2 	 MedChem 's
13 	 10 	 (NP\NP)/NP 	 2 	 sales of
13 	 12 	 (NP[nb]/N)\NP 	 1 	 sales 's
16 	 6 	 (S[dcl]\NP)/NP 	 2 	 % contribute
16 	 15 	 N/N 	 1 	 % 10
16 	 17 	 (N\N)/N 	 1 	 % to
16 	 20 	 (NP\NP)/NP 	 1 	 % of
19 	 17 	 (N\N)/N 	 2 	 % to
19 	 18 	 N/N 	 1 	 % 20
22 	 20 	 (NP\NP)/NP 	 2 	 earnings of
22 	 21 	 NP[nb]/N 	 1 	 earnings its
<\s>
<s id="wsj_2336.6"> 27
2 	 0 	 (S/S)/NP 	 2 	 year In
2 	 1 	 NP[nb]/N 	 1 	 year the
2 	 3 	 S[pss]\NP 	 1 	 year ended <XB>
3 	 4 	 ((S\NP)\(S\NP))/N[num] 	 2 	 ended Aug.
4 	 7 	 ((S\NP)\(S\NP))\((S\NP)\(S\NP)) 	 3 	 Aug. 1988
5 	 4 	 ((S\NP)\(S\NP))/N[num] 	 3 	 31 Aug.
9 	 10 	 (S[dcl]\NP)/NP 	 1 	 MedChem earned
10 	 0 	 (S/S)/NP 	 1 	 earned In
10 	 21 	 ((S\NP)\(S\NP))/NP 	 2 	 earned on
11 	 10 	 (S[dcl]\NP)/NP 	 2 	 $ earned
13 	 11 	 N/N[num] 	 1 	 million $
13 	 12 	 N/N 	 1 	 million 2.9
17 	 10 	 (S[dcl]\NP)/NP 	 2 	 cents earned
17 	 16 	 N/N 	 1 	 cents 72
17 	 18 	 (NP\NP)/N 	 1 	 cents a
19 	 18 	 (NP\NP)/N 	 2 	 share a
22 	 21 	 ((S\NP)\(S\NP))/NP 	 3 	 sales on
22 	 23 	 (NP\NP)/NP 	 1 	 sales of
24 	 23 	 (NP\NP)/NP 	 2 	 $ of
26 	 24 	 N/N[num] 	 1 	 million $
26 	 25 	 N/N 	 1 	 million 17.4
<\s>
<s id="wsj_2336.7"> 28
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 MedChem said
3 	 2 	 NP[nb]/N 	 1 	 court the
3 	 4 	 (NP[nb]/N)\NP 	 2 	 court 's
5 	 4 	 (NP[nb]/N)\NP 	 1 	 ruling 's
5 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 ruling was
5 	 7 	 S[pss]\NP 	 1 	 ruling issued <XB>
5 	 19 	 (S[dcl]\NP)/NP 	 1 	 ruling concerns <XU>
6 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 was said
7 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 issued was
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 issued as
9 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 part as
9 	 10 	 (NP\NP)/NP 	 1 	 part of
13 	 10 	 (NP\NP)/NP 	 2 	 trial of
13 	 11 	 NP[nb]/N 	 1 	 trial a
13 	 12 	 N/N 	 1 	 trial first-phase
13 	 14 	 (NP\NP)/NP 	 1 	 trial in
17 	 14 	 (NP\NP)/NP 	 2 	 proceedings in
17 	 15 	 NP[nb]/N 	 1 	 proceedings the
17 	 16 	 N/N 	 1 	 proceedings patent-infringement
19 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 concerns said
21 	 19 	 (S[dcl]\NP)/NP 	 2 	 one concerns
21 	 20 	 N/N 	 1 	 one only
21 	 22 	 (NP\NP)/NP 	 1 	 one of
24 	 22 	 (NP\NP)/NP 	 2 	 defenses of
24 	 23 	 NP[nb]/N 	 1 	 defenses its
24 	 25 	 (NP\NP)/NP 	 1 	 defenses in
27 	 25 	 (NP\NP)/NP 	 2 	 case in
27 	 26 	 NP[nb]/N 	 1 	 case the
<\s>
<s id="wsj_2336.8"> 19
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 It said
2 	 3 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 it is
2 	 4 	 (S[ng]\NP)/NP 	 1 	 it considering <XB>
3 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 is said
4 	 3 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 considering is
4 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 considering in
4 	 15 	 ((S\NP)\(S\NP))/NP 	 2 	 considering including
5 	 4 	 (S[ng]\NP)/NP 	 2 	 all considering
5 	 6 	 (NP\NP)/NP 	 1 	 all of
8 	 6 	 (NP\NP)/NP 	 2 	 options of
8 	 7 	 NP[nb]/N 	 1 	 options its
10 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 light in
10 	 11 	 (NP\NP)/NP 	 1 	 light of
13 	 11 	 (NP\NP)/NP 	 2 	 decision of
13 	 12 	 NP[nb]/N 	 1 	 decision the
18 	 15 	 ((S\NP)\(S\NP))/NP 	 3 	 appeal including
18 	 16 	 NP[nb]/N 	 1 	 appeal a
18 	 17 	 N/N 	 1 	 appeal possible
<\s>
<s id="wsj_2336.9"> 29
2 	 0 	 NP[nb]/N 	 1 	 company The
2 	 1 	 N/N 	 1 	 company medical-products
2 	 3 	 (S[dcl]\NP)/S[em] 	 1 	 company added
4 	 3 	 (S[dcl]\NP)/S[em] 	 2 	 that added
5 	 6 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 it plans
5 	 8 	 (S[b]\NP)/NP 	 1 	 it assert <XB>
6 	 4 	 S[em]/S[dcl] 	 1 	 plans that
7 	 6 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to plans
8 	 7 	 (S[to]\NP)/(S[b]\NP) 	 2 	 assert to
11 	 8 	 (S[b]\NP)/NP 	 2 	 defenses assert
11 	 9 	 NP[nb]/N 	 1 	 defenses its
11 	 10 	 N/N 	 1 	 defenses other
11 	 12 	 (NP\NP)/NP 	 1 	 defenses against
11 	 17 	 (NP\NP)/NP 	 1 	 defenses including
13 	 14 	 (NP[nb]/N)\NP 	 2 	 Pharmacia 's
15 	 12 	 (NP\NP)/NP 	 2 	 lawsuit against
15 	 14 	 (NP[nb]/N)\NP 	 1 	 lawsuit 's
19 	 17 	 (NP\NP)/NP 	 2 	 claim including
19 	 18 	 NP[nb]/N 	 1 	 claim the
20 	 19 	 N/S[em] 	 1 	 that claim
21 	 22 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 it has
21 	 24 	 (S[pt]\NP)/PP 	 1 	 it infringed <XB>
22 	 20 	 S[em]/S[dcl] 	 1 	 has that
22 	 23 	 (S\NP)\(S\NP) 	 2 	 has n't
24 	 22 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 infringed has
25 	 24 	 (S[pt]\NP)/PP 	 2 	 on infringed
26 	 27 	 (NP[nb]/N)\NP 	 2 	 Pharmacia 's
28 	 25 	 PP/NP 	 1 	 patent on
28 	 27 	 (NP[nb]/N)\NP 	 1 	 patent 's
<\s>
<s id="wsj_2336.10"> 26
0 	 1 	 (S[dcl]\NP)/S[em] 	 1 	 MedChem said
2 	 1 	 (S[dcl]\NP)/S[em] 	 2 	 that said
4 	 3 	 NP[nb]/N 	 1 	 court the
4 	 5 	 ((S[dcl]\NP)/PP)/NP 	 1 	 court scheduled
5 	 2 	 S[em]/S[dcl] 	 1 	 scheduled that
5 	 11 	 ((S\NP)\(S\NP))/S[to] 	 2 	 scheduled --
7 	 5 	 ((S[dcl]\NP)/PP)/NP 	 3 	 conference scheduled
7 	 6 	 NP[nb]/N 	 1 	 conference a
8 	 5 	 ((S[dcl]\NP)/PP)/NP 	 2 	 for scheduled
10 	 8 	 PP/NP 	 1 	 Monday for
10 	 9 	 N/N 	 1 	 Monday next
12 	 11 	 ((S\NP)\(S\NP))/S[to] 	 3 	 to --
13 	 12 	 S[to]/(S[b]\NP) 	 1 	 set to
15 	 13 	 (S[b]\NP)/NP 	 2 	 date set
15 	 14 	 NP[nb]/N 	 1 	 date a
15 	 16 	 (NP\NP)/NP 	 1 	 date for
17 	 16 	 (NP\NP)/NP 	 2 	 proceedings for
17 	 18 	 (NP\NP)/NP 	 1 	 proceedings on
19 	 20 	 (NP[nb]/N)\NP 	 2 	 Pharmacia 's
21 	 18 	 (NP\NP)/NP 	 2 	 motion on
21 	 20 	 (NP[nb]/N)\NP 	 1 	 motion 's
21 	 22 	 (NP\NP)/NP 	 1 	 motion for
25 	 22 	 (NP\NP)/NP 	 2 	 injunction for
25 	 23 	 NP[nb]/N 	 1 	 injunction a
25 	 24 	 N/N 	 1 	 injunction preliminary
<\s>
